BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

PCI Biotech 

Hoffsveien 48

Oslo    N-0377  Norway
Phone: 47-23-254003 Fax: 47-23-254001


SEARCH JOBS


Industry
Biotechnology






 Company News
New Data Confirms Early Implantation of Impella 2.5 Prior to PCI Biotech Improves Survival in Shock Patients 11/11/2011 6:27:37 AM    More...
Main Results of the Full Phase I/II Study of PCI Biotech's Amphinex(R) 6/27/2011 9:55:53 AM    More...
PCI Biotech: Main Results of the Full Phase I/II study of Amphinex(R) 6/24/2011 9:36:34 AM    More...
PCI Biotech Announces Last Patient Included in the Phase I/II Study of PC-A11 2/23/2011 7:49:12 AM    More...
PCI Biotech Raises NOK90 Million in Rights Issue 6/10/2010 6:39:26 AM    More...
PCI Biotech Reports Successful Completion of the Third Dose Group in the Phase I/II Amphinex(R) Trial 3/16/2010 9:52:58 AM    More...
PCI Biotech Reports Successful Completion of Second Dose Group in Pivotal Amphinex(R) Trial 1/19/2010 10:07:50 AM    More...
PCI Biotech Commences Phase I/II Trials of Amphinex(R) Light-Mediated Therapy Aims to Overcome Both Tumour Cell Uptake Barriers and Toxicity Problems 8/24/2009 8:04:30 AM    More...
PCI Biotech: Anti-Tumour Drug More Potent With Light-Directed Delivery 8/19/2009 7:55:35 AM    More...
PCI Biotech’s Photochemical Technology Shows Clinical Potential In Mouse Models 7/13/2009 1:13:14 PM    More...
12

//-->